Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GlaxoSmithKline divulges new DGAT1 inhibitors

June 17, 2014

U.S. investigators patent new compounds for diabetes and obesity

June 13, 2014

FDA extends review date of NB-32 NDA

June 12, 2014

U.S. investigators disclose novel compounds for lysosomal storage diseases

June 12, 2014

EffRx Pharmaceuticals obtains FDA orphan drug status for metformin in PCOS

June 11, 2014

LG Life Sciences discloses new GPR40 agonists

June 10, 2014

GlaxoSmithKline patent describes novel DGAT1 inhibitors for obesity

June 5, 2014

Health Canada accepts Ravicti NDS for priority review

June 4, 2014

Teriparatide evidences potential for spinal fusion and fractures

June 4, 2014

Merrion Pharmaceuticals' GIPET technology advances with Novo Nordisk oral insulin development

June 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026